All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

BD bids farewell to its diagnostic, bioscience divisions with company split

BD bids farewell to its diagnostic, bioscience division...

Feb 9, 2025  0

NIH cancels grants for LGBTQ+ health research effective immediately: Stat

NIH cancels grants for LGBTQ+ health research effective...

Mar 5, 2025  0

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

Allogene’s phase 1 lymphoma data show CAR-T could ‘leap...

Feb 14, 2025  0